Details

NameSymbolSector
GLENMARK PHARMACEUTICALS LIMITEDGLENMARKPharmaceuticals
Open
2039.3
High
2052.8
Low
2017
Close
2044.6
Volume
986277
Exchange
nse
Time
14/08

Outlook

Score:  

2.25

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Glenmark Pharmaceuticals is  
Harami
Estimated Stoploss of Glenmark Pharmaceuticals is ₹  
2017
Glenmark Pharmaceuticals has a  
Bullishℹ
 pattern. 
Formation of  
Harami
 candle pattern indicates Glenmark Pharmaceuticals has chances of  
Reversalℹ
 to up trend 

Trend

Glenmark Pharmaceuticals is in  
Downtrendℹ
. 
Price of Glenmark Pharmaceuticals is  
Upℹ
 by  

3.36

%. 
Target
Buy @ 

1630.1

Sell @ 

2069.3

Volume

The trade volumes of Glenmark Pharmaceuticals have become  
Deficientℹ
Though the volume trend for Glenmark Pharmaceuticals appears  
Bullishℹ
 the participants seem to be  
Weak Buyersℹ
The trade volume of Glenmark Pharmaceuticals is  

Down

 by  

30.16

% 

Valuation

The current market price of Glenmark Pharmaceuticals is  
Undervaluedℹ

Financials

Balance
The balance sheet of Glenmark Pharmaceuticals is:  

Balanced

Cashflow
Glenmark Pharmaceuticals has  
Maintainedℹ
 cash flow because there is  

Surplus

 of  

₹ 17cr

. It is  
Downℹ
 by  

92.09

%. 

(*Mar 2025)

49.49% i.e. ₹ 827cr spent in operatingℹ
0.12% i.e. ₹ 2cr earned in investingℹ
47.1% i.e. ₹ 787cr earned in financingℹ
3.29% i.e. ₹ 55cr earned in otherℹ
Glenmark Pharmaceuticals has  
Excellentℹ
 cash flow because there is  

Surplus

 of  

₹ 215cr

. It is  
Upℹ
 by  

571.88

%. 

(*Mar 2024)

2.98% i.e. ₹ 265cr spent in operatingℹ
51.21% i.e. ₹ 4560cr earned in investingℹ
43.86% i.e. ₹ 3906cr spent in financingℹ
1.95% i.e. ₹ 174cr spent in otherℹ
Income
The income of Glenmark Pharmaceuticals is  

₹ 3290cr

 and  

Profit

 is :  

₹ 46cr

(*Jun 2025)

Glenmark Pharmaceuticals Profit is up by:  

1050

% and Income is Up by:  

0.7

% 

(*Jun 2025)

The income of Glenmark Pharmaceuticals is  

₹ 3267cr

 and  

Profit

 is :  

₹ 4cr

(*Mar 2025)

Glenmark Pharmaceuticals Profit is down by:  

98.85

% and Income is Down by:  

4.42

% 

(*Mar 2025)

The income of Glenmark Pharmaceuticals is  

₹ 3418cr

 and  

Profit

 is :  

₹ 348cr

(*Dec 2024)

Glenmark Pharmaceuticals Profit is down by:  

1.69

% and Income is Down by:  

1.58

% 

(*Dec 2024)

By using this site you agree to the use of cookies to deliver a better site experience.